The Extracellular Signal-Regulated Kinase Mitogen- Activated Protein Kinase Pathway in Osteoblasts

키워드

참고문헌 (117)

1. Herskowitz I, "MAP kinase pathways in yeast : for mating and more", Cell, 80, pp.187~197 (1995)[DOI]
2. Posas F, "Osmotic activation of the HOG MAPK pathway via Ste11p MAPKKK : scaffold role of Pbs2p MAPKK", Science, 276, pp.1702~1705 (1997)[DOI]
3. Li M, "Evolutionary history of the vertebrate mitogen activated protein kinases family", PLoS One, 6, pp.e26999~ (2011)[DOI]
4. Xu R, "c-Jun N-terminal kinases(JNKs)are critical mediators of osteoblast activity in vivo", J Bone Miner Res, 32, pp.1811~1815 (2017)[DOI]
5. Greenblatt MB, "The p38 MAPK pathway is essential for skeletogenesis and bone homeostasis in mice", J Clin Invest, 120, pp.2457~2473 (2010)[DOI]
6. Ge C, "Critical role of the extracellular signal-regulated kinase-MAPK pathway in osteoblast differentiation and skeletal development", J Cell Biol, 176, pp.709~718 (2007)[DOI]
7. Franceschi RT, "Control of the osteoblast lineage by mitogen-activated protein kinase signaling", Curr Mol Biol Rep, 3, pp.122~132 (2017)[DOI]
8. Kim JM, "The ERK MAPK pathway is essential for skeletal development and homeostasis", Int J Mol Sci, 20, pp.1803~ (2019)[DOI]
9. Stevenson DA, "Multiple increased osteoclast functions in individuals with neurofibromatosis type 1", Am J Med Genet A, 155a, pp.1050~1059 (2011)[DOI]
10. David JP, "JNK1 modulates osteoclastogenesis through both c-Jun phosphorylation-dependent and-independent mechanisms", J Cell Sci, 115, pp.4317~4325 (2002)[DOI]
11. Matsumoto M, "Involvement of p38 mitogen-activated protein kinase signaling pathway in osteoclastogenesis mediated by receptor activator of NF-kappa B ligand(RANKL)", J Biol Chem, 275, pp.31155~31161 (2000)[DOI]
12. Lee SE, "The phosphatidylinositol 3-kinase, p38, and extracellular signal-regulated kinase pathways are involved in osteoclast differentiation", Bone, 30, pp.71~77 (2002)[DOI]
13. Lee SE, "Tumor necrosis factor-alpha supports the survival of osteoclasts through the activation of Akt and ERK", J Biol Chem, 276, pp.49343~49349 (2001)[DOI]
14. Frémin C, "Functional redundancy of ERK1 and ERK2 MAP kinases during development", Cell Rep, 12, pp.913~921 (2015)[DOI]
15. Saba-El-Leil MK, "Redundancy in the world of MAP kinases : All for one", Front Cell Dev Biol, 4, pp.67~ (2016)[DOI]
16. Aoidi R, "Functional redundancy of the kinases MEK1 and MEK2 : Rescue of the Mek1 mutant phenotype by Mek2 knock-in reveals a protein threshold effect", Sci Signal, 9, pp.ra9~ (2016)[DOI]
17. Yaeger R, "Targeting alterations in the RAF-MEK pathway", Cancer Discov, 9, pp.329~341 (2019)[DOI]
18. Robert C, "Improved overall survival in melanoma with combined dabrafenib and trametinib", N Engl J Med, 372, pp.30~39 (2015)[DOI]
19. Chapman PB, "Improved survival with vemurafenib in melanoma with BRAF V600E mutation", N Engl J Med, 364, pp.2507~2516 (2011)[DOI]
20. Hong DS, "KRAS(G12C)inhibition with sotorasib in advanced solid tumors", N Engl J Med, 383, pp.1207~1217 (2020)[DOI]
21. Skoulidis F, "Sotorasib for lung cancers with KRAS p.G12C mutation", N Engl J Med, 384, pp.2371~2381 (2021)[DOI]
22. Welsh SJ, "Management of BRAF and MEK inhibitor toxicities in patients with metastatic melanoma", Ther Adv Med Oncol, 7, pp.122~136 (2015)[DOI]
23. Elefteriou F, "ATF4 mediation of NF1 functions in osteoblast reveals a nutritional basis for congenital skeletal dysplasiae", Cell Metab, 4, pp.441~451 (2006)[DOI]
24. Ono K, "The ras-GTPase activity of neurofibromin restrains ERK-dependent FGFR signaling during endochondral bone formation", Hum Mol Genet, 22, pp.3048~3062 (2013)[DOI]
25. Matsushita T, "Extracellular signal-regulated kinase 1(ERK1)and ERK2 play essential roles in osteoblast differentiation and in supporting osteoclastogenesis", Mol Cell Biol, 29, pp.5843~5857 (2009)[DOI]
26. Mizuhashi K, "Resting zone of the growth plate houses a unique class of skeletal stem cells", Nature, 563, pp.254~258 (2018)[DOI]
27. Zhou X, "Chondrocytes transdifferentiate into osteoblasts in endochondral bone during development, postnatal growth and fracture healing in mice", PLoS Genet, 10, pp.e1004820~ (2014)[DOI]
28. Yang L, "Hypertrophic chondrocytes can become osteoblasts and osteocytes in endochondral bone formation", Proc Natl Acad Sci U S A, 111, pp.12097~12102 (2014)[DOI]
29. Debnath S, "Discovery of a periosteal stem cell mediating intramembranous bone formation", Nature, 562, pp.133~139 (2018)[DOI]
30. Matsushita Y, "A Wnt-mediated transformation of the bone marrow stromal cell identity orchestrates skeletal regeneration", Nat Commun, 11, pp.332~ (2020)[DOI]
31. Seike M, "Stem cell niche-specific Ebf3 maintains the bone marrow cavity", Genes Dev, 32, pp.359~372 (2018)[DOI]
32. Zhou BO, "Leptin-receptor-expressing mesenchymal stromal cells represent the main source of bone formed by adult bone marrow", Cell Stem Cell, 15, pp.154~168 (2014)[DOI]
33. De Simone A, "Control of osteoblast regeneration by a train of Erk activity waves", Nature, 590, pp.129~133 (2021)[DOI]
34. Su N, "Role of FGF", FGFR signaling in skeletal development and homeostasis : learning from mouse models, 2014, pp.2, 14003~
35. Xiao G, "Fibroblast growth factor 2 induction of the osteocalcin gene requires MAPK activity and phosphorylation of the osteoblast transcription factor, Cbfa1", Runx2, 2002, pp.277, 36181~36187
36. Ge C, "Identification and functional characterization of ERK", MAPK phosphorylation sites in the Runx2 transcription factor, 2009, pp.284, 32533~32543
37. Yin L, "A Pro253Arg mutation in fibroblast growth factor receptor 2(Fgfr2)causes skeleton malformation mimicking human Apert syndrome by affecting both chondrogenesis and osteogenesis", Bone, 42, pp.631~643 (2008)[DOI]
38. Park WJ, "Analysis of phenotypic features and FGFR2 mutations in Apert syndrome", Am J Hum Genet, 57, pp.321~328 (1995)
39. Shukla V, "RNA interference and inhibition of MEK-ERK signaling prevent abnormal skeletal phenotypes in a mouse model of craniosynostosis", Nat Genet, 39, pp.1145~1150 (2007)[DOI]
40. Park J, "Functional characterization of a novel FGFR2 mutation, E731K, in craniosynostosis", J Cell Biochem, 113, pp.457~464 (2012)[DOI]
41. Yoon WJ, "Prolyl isomerase Pin1-mediated conformational change and subnuclear focal accumulation of Runx2 are crucial for fibroblast growth factor 2(FGF2)-induced osteoblast differentiation", J Biol Chem, 289, pp.8828~8838 (2014)[DOI]
42. Shin HR, "PIN1 is a new therapeutic target of craniosynostosis", Hum Mol Genet, 27, pp.3827~3839 (2018)[DOI]
43. Park OJ, "FGF2-activated ERK mitogen-activated protein kinase enhances Runx2 acetylation and stabilization", J Biol Chem, 285, pp.3568~3574 (2010)[DOI]
44. Kim HJ, "Erk pathway and activator protein 1 play crucial roles in FGF2-stimulated premature cranial suture closure", Dev Dyn, 227, pp.335~346 (2003)[DOI]
45. Wang Y, "Autocrine and paracrine actions of IGF-I signaling in skeletal development", Bone Res, 1, pp.249~259 (2013)[DOI]
46. Zhao G, "Targeted overexpression of insulin-like growth factor I to osteoblasts of transgenic mice : increased trabecular bone volume without increased osteoblast proliferation", Endocrinology, 141, pp.2674~2682 (2000)[DOI]
47. Houschyar KS, "Wnt pathway in bone repair and regeneration : What do we know so far", Front Cell Dev Biol, 6, pp.170~ (2018)[DOI]
48. Zhang M, "Osteoblast-specific knockout of the insulin-like growth factor(IGF)receptor gene reveals an essential role of IGF signaling in bone matrix mineralization", J Biol Chem, 277, pp.44005~44012 (2002)[DOI]
49. Zhang W, "Effects of insulin and insulin-like growth factor 1 on osteoblast proliferation and differentiation : differential signalling via Akt and ERK", Cell Biochem Funct, 30, pp.297~302 (2012)[DOI]
50. Celil AB, "BMP-2 and insulin-like growth factor-I mediate Osterix(Osx)expression in human mesenchymal stem cells via the MAPK and protein kinase D signaling pathways", J Biol Chem, 280, pp.31353~31359 (2005)[DOI]
51. Shim JH, "Schnurri-3 regulates ERK downstream of WNT signaling in osteoblasts", J Clin Invest, 123, pp.4010~4022 (2013)[DOI]
52. Caverzasio J, "Essential role of Wnt3a-mediated activation of mitogen-activated protein kinase p38 for the stimulation of alkaline phosphatase activity and matrix mineralization in C3H10T1", 2 mesenchymal cells, 2007, pp.148, 5323~5330
53. Albers J, "Control of bone formation by the serpentine receptor Frizzled-9", J Cell Biol, 192, pp.1057~1072 (2011)[DOI]
54. Wu M, "TGF-β and BMP signaling in osteoblast, skeletal development, and bone formation, homeostasis and disease", Bone Res, 4, pp.16009~ (2016)[DOI]
55. Matsunobu T, "Critical roles of the TGF-beta type I receptor ALK5 in perichondrial formation and function, cartilage integrity, and osteoblast differentiation during growth plate development", Dev Biol, 332, pp.325~338 (2009)[DOI]
56. Lai CF, "Signal transductions induced by bone morphogenetic protein-2 and transforming growth factor-beta in normal human osteoblastic cells", J Biol Chem, 277, pp.15514~15522 (2002)[DOI]
57. Xiao G, "Bone morphogenetic proteins, extracellular matrix, and mitogen-activated protein kinase signaling pathways are required for osteoblast-specific gene expression and differentiation in MC3T3-E1 cells", J Bone Miner Res, 17, pp.101~110 (2002)[DOI]
58. Huang RL, "Opposing TNF-α", IL-1β-and BMP-2-activated MAPK signaling pathways converge on Runx2 to regulate BMP-2-induced osteoblastic differentiation, 2014, pp.5, e1187~
59. Jeon EJ, "Bone morphogenetic protein-2 stimulates Runx2 acetylation", J Biol Chem, 281, pp.16502~16511 (2006)[DOI]
60. Provot S, "A-raf and B-raf are dispensable for normal endochondral bone development, and parathyroid hormone-related peptide suppresses extracellular signal-regulated kinase activation in hypertrophic chondrocytes", Mol Cell Biol, 28, pp.344~357 (2008)[DOI]
61. Papaioannou G, "Raf kinases are essential for phosphate induction of ERK1", 2 phosphorylation in hypertrophic chondrocytes and normal endochondral bone development, 2017, pp.292, 3164~3171
62. Zou W, "MLK3 regulates bone development downstream of the faciogenital dysplasia protein FGD1 in mice", J Clin Invest, 121, pp.4383~4392 (2011)[DOI]
63. Zheng Y, "The faciogenital dysplasia gene product FGD1 functions as a Cdc42Hs-specific guanine-nucleotide exchange factor", J Biol Chem, 271, pp.33169~33172 (1996)[DOI]
64. Blank JL, "Molecular cloning of mitogen-activated protein", ERK kinase kinases (MEKK) 2 and 3. Regulation of sequential phosphorylation pathways involving mitogen-activated protein kinase and c-Jun kinase, 1996, pp.271, 5361~5368
65. Sun W, "MEK kinase 2 and the adaptor protein Lad regulate extracellular signal-regulated kinase 5 activation by epidermal growth factor via Src", Mol Cell Biol, 23, pp.2298~2308 (2003)[DOI]
66. Cheng J, "Synergistic interaction of MEK kinase 2, c-Jun N-terminal kinase (JNK) kinase 2, and JNK1 results in efficient and specific JNK1 activation", Mol Cell Biol, 20, pp.2334~2342 (2000)[DOI]
67. Kesavan K, "MEKK2 regulates the coordinate activation of ERK5 and JNK in response to FGF-2 in fibroblasts", J Cell Physiol, 199, pp.140~148 (2004)[DOI]
68. Greenblatt MB, "MEKK2 mediates an alternative β-catenin pathway that promotes bone formation", Proc Natl Acad Sci U S A, 113, pp.E1226~E1235 (2016)[DOI]
69. Yamashita M, "Ubiquitin ligase Smurf1 controls osteoblast activity and bone homeostasis by targeting MEKK2 for degradation", Cell, 121, pp.101~113 (2005)[DOI]
70. Bok S, "MEKK2 mediates aberrant ERK activation in neurofibromatosis type I", Nat Commun, 11, pp.5704~ (2020)[DOI]
71. Wang W, "Mice lacking Nf1 in osteochondroprogenitor cells display skeletal dysplasia similar to patients with neurofibromatosis type I", Hum Mol Genet, 20, pp.3910~3924 (2011)[DOI]
72. Friedman JM, "Epidemiology of neurofibromatosis type 1", Am J Med Genet, 89, pp.1~6 (1999)
73. Stevenson DA, "Descriptive analysis of tibial pseudarthrosis in patients with neurofibromatosis 1", Am J Med Genet, 84, pp.413~419 (1999)[DOI]
74. Ferner RE, "Guidelines for the diagnosis and management of individuals with neurofibromatosis 1", J Med Genet, 44, pp.81~88 (2007)[DOI]
75. Crawford AH, "Neurofibromatosis in children : the role of the orthopaedist", J Am Acad Orthop Surg, 7, pp.217~230 (1999)[DOI]
76. Elefteriou F, "Skeletal abnormalities in neurofibromatosis type 1 : approaches to therapeutic options", Am J Med Genet A, 149a, pp.2327~2338 (2009)[DOI]
77. Kolanczyk M, "Multiple roles for neurofibromin in skeletal development and growth", Hum Mol Genet, 16, pp.874~886 (2007)[DOI]
78. de la Croix Ndong J, "Asfotase-α improves bone growth, mineralization and strength in mouse models of neurofibromatosis type-1", Nat Med, 20, pp.904~910 (2014)[DOI]
79. Neel BG, "The 'Shp'ing news : SH2 domain-containing tyrosine phosphatases in cell signaling", Trends Biochem Sci, 28, pp.284~293 (2003)[DOI]
80. Zuo C, "SHP2 regulates skeletal cell fate by modifying SOX9 expression and transcriptional activity", Bone Res, 6, pp.12~ (2018)[DOI]
81. Uhlén P, "Gain-of-function", Noonan syndrome SHP-2, Proc Natl Acad Sci U S A, pp.2006, 103[DOI]
82. Roberts AE, "Germline gain-of-function mutations in SOS1 cause Noonan syndrome", Nat Genet, 39, pp.70~74 (2007)[DOI]
83. Choudhry KS, "Decreased bone mineralization in children with Noonan syndrome : another consequence of dysregulated RAS MAPKinase pathway?", Mol Genet Metab, 106, pp.237~240 (2012)[DOI]
84. Binder G, "Noonan syndrome, the Ras-MAPK signalling pathway and short stature", Horm Res, 71(Suppl 2), pp.64~70 (2009)[DOI]
85. Yang W, "Ptpn11 deletion in a novel progenitor causes metachondromatosis by inducing hedgehog signalling", Nature, 499, pp.491~495 (2013)[DOI]
86. Bowen ME, "Loss-of-function mutations in PTPN11 cause metachondromatosis, but not Ollier disease or Maffucci syndrome", PLoS Genet, 7, pp.e1002050~ (2011)[DOI]
87. Bowen ME, "SHP2 regulates chondrocyte terminal differentiation, growth plate architecture and skeletal cell fates", PLoS Genet, 10, pp.e1004364~ (2014)[DOI]
88. Wang L, "Targeted Ptpn11 deletion in mice reveals the essential role of SHP2 in osteoblast differentiation and skeletal homeostasis", Bone Res, 9, pp.6~ (2021)[DOI]
89. Greenblatt MB, "Mitogen-activated protein kinase pathways in osteoblasts", Annu Rev Cell Dev Biol, 29, pp.63~79 (2013)[DOI]
90. Li Z, "TAOK3 is a MAP3K contributing to osteoblast differentiation and skeletal mineralization", Biochem Biophys Res Commun, 531, pp.497~502 (2020)[DOI]
91. Dar AC, "The evolution of protein kinase inhibitors from antagonists to agonists of cellular signaling", Annu Rev Biochem, 80, pp.769~795 (2011)[DOI]
92. Muniyappa H, "Activation of c-Jun N-terminal kinase(JNK)by widely used specific p38 MAPK inhibitors SB202190 and SB203580 : a MLK-3-MKK7-dependent mechanism", Cell Signal, 20, pp.675~683 (2008)[DOI]
93. Xiao G, "MAPK pathways activate and phosphorylate the osteoblast-specific transcription factor, Cbfa1", J Biol Chem, 275, pp.4453~4459 (2000)[DOI]
94. Ge C, "Interactions between extracellular signal-regulated kinase 1", 2 and p38 MAP kinase pathways in the control of RUNX2 phosphorylation and transcriptional activity, 2012, pp.27, 538~551
95. 김우진, "RUNX2-modifying enzymes: therapeutic targets for bone diseases", Experimental and Molecular Medicine, 52, pp.1~7 (2020), 생화학분자생물학회[DOI]
96. Yoon WJ, "Pin1-mediated Runx2 modification is critical for skeletal development", J Cell Physiol, 228, pp.2377~2385 (2013)[DOI]
97. Otto F, "Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development", Cell, 89, pp.765~771 (1997)[DOI]
98. Mundlos S, "Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia", Cell, 89, pp.773~779 (1997)[DOI]
99. Smith JA, "Identification of an extracellular signal-regulated kinase (ERK) docking site in ribosomal S6 kinase, a sequence critical for activation by ERK in vivo", J Biol Chem, 274, pp.2893~2898 (1999)[DOI]
100. Trivier E, "Mutations in the kinase Rsk-2 associated with Coffin-Lowry syndrome", Nature, 384, pp.567~570 (1996)[DOI]
101. Wang ZQ, "Bone and haematopoietic defects in mice lacking c-fos", Nature, 360, pp.741~745 (1992)[DOI]
102. Jochum W, "Increased bone formation and osteosclerosis in mice overexpressing the transcription factor Fra-1", Nat Med, 6, pp.980~984 (2000)[DOI]
103. Eferl R, "The Fos-related antigen Fra-1 is an activator of bone matrix formation", EMBO J, 23, pp.2789~2799 (2004)[DOI]
104. Bakiri L, "Functions of Fos phosphorylation in bone homeostasis, cytokine response and tumourigenesis", Oncogene, 30, pp.1506~1517 (2011)[DOI]
105. Nithianandarajah-Jones GN, "ERK5: structure, regulation and function", Cell Signal, 24, pp.2187~2196 (2012)[DOI]
106. Zhou G, "Components of a new human protein kinase signal transduction pathway", J Biol Chem, 270, pp.12665~12669 (1995)[DOI]
107. Nishimoto S, "MAPK signalling : ERK5 versus ERK1", 2, 2006, pp.7, 782~786
108. Wang X, "Targeted deletion of mek5 causes early embryonic death and defects in the extracellular signal-regulated kinase 5", myocyte enhancer factor 2 cell survival pathway, 2005, pp.25, 336~345
109. Ding N, "Fluid shear stress promotes osteoblast proliferation through the NFATc1-ERK5 pathway", Connect Tissue Res, 60, pp.107~116 (2019)[DOI]
110. Kaneshiro S, "MEK5 suppresses osteoblastic differentiation", Biochem Biophys Res Commun, 463, pp.241~247 (2015)[DOI]
111. Loveridge CJ, "Analysis of Nkx3.1:Cre-driven Erk5 deletion reveals a profound spinal deformity which is linked to increased osteoclast activity", Sci Rep, 7, pp.13241~ (2017)[DOI]
112. Iezaki T, "The MAPK Erk5 is necessary for proper skeletogenesis involving a Smurf-Smad-Sox9 molecular axis", Development, 145, pp.dev164004~ (2018)[DOI]
113. Ambrosi TH, "Distinct skeletal stem cell types orchestrate long bone skeletogenesis", Elife, 10, pp.e66063~ (2021)[DOI]
114. Chan CK, "Identification and specification of the mouse skeletal stem cell", Cell, 160, pp.285~298 (2015)[DOI]
115. Chan CKF, "Identification of the human skeletal stem cell", Cell, 175, pp.43~56 (2018)[DOI]
116. Matthews BG, "Analysis of αSMA-labeled progenitor cell commitment identifies notch signaling as an important pathway in fracture healing", J Bone Miner Res, 29, pp.1283~1294 (2014)[DOI]
117. Shen B, "A mechanosensitive peri-arteriolar niche for osteogenesis and lymphopoiesis", Nature, 591, pp.438~444 (2021)[DOI]

관련 논문AI추천